FDA Clearance Tracker · K143589
GEM Flow COUPLER Device and System
Last checked: Nov 19, 2026Latest source record: Jan 16, 2015 (this decision)Source: openFDAMethods & limitations
Decided
Jan 16, 2015
Substantially Equivalent
Time to decision
29 days
Received Dec 18, 2014. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Special
Device class
Class II
The decision
- FDA number
- K143589
- Device name
- GEM Flow COUPLER Device and System
- Applicant
- Synovis Life Technologies, Inc.
- Applicant location
- St. Paul, MN
- Received
- Dec 18, 2014
- Decided
- Jan 16, 2015
- Decision
- Substantially Equivalent
- Submission type
- Special
Device type
- Device type
- Device, Anastomotic, Microvascular (MVR)
- Device class
- Class II
- Regulation
- 21 CFR 878.4300
- Specialty
- General & Plastic Surgery
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code MVR. The earliest in FDA's data is K861985, decided Dec 4, 1986.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K143589
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Synovis Life Technologies, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K260431 · Decided Nov 5, 2026 · 282 days after receipt
Device type: Dura Substitute (GXQ) · Neurology & Neurosurgery
K223052 · Decided Apr 7, 2023 · 190 days after receipt
Device type: Mesh, Surgical (FTM) · General & Plastic Surgery
K221029 · Decided Oct 19, 2022 · 195 days after receipt
Device type: Intracardiac Patch Or Pledget, Biologically Derived (PSQ) · Cardiology
4 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.